SCPH stock forecast
Our latest prediction for scPharmaceuticals, Inc.'s stock price was made on the April 11, 2019 when the stock price was at 2.62$.
In the short term (2weeks), SCPH's stock price should outperform the market by 6.11%. During that period the price should oscillate between -7.53% and +15.42%.
In the medium term (3months), SCPH's stock price should outperform the market by 7.55%. During that period the price should oscillate between -17.31% and +39.60%.Get email alerts
Create a solid portfolio with SCPH
About scPharmaceuticals, Inc.
scPharmaceuticals, Inc.engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include furosemide, used as parenteral diuretic in treating heart failure and ceftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.65$ per share.
The book value per share is 4.76$
Three months stock forecastApril 11, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|